PFS
IRWD icon

Prospera Financial Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Prospera Financial Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,067
Closed -$251K – 1084
2023
Q3 		$251K Hold
26,067
– – 0.01% 871
2023
Q2 		$277K Buy
26,067
+2,197
+9% +$23.6K 0.01% 835
2023
Q1 		$251K Buy
23,870
+924
+4% +$10.4K 0.01% 840
2022
Q4 		$284K Buy
22,946
+1,222
+6% +$13.9K 0.01% 729
2022
Q3 		$225K Buy
21,724
+2,129
+11% +$24.1K 0.01% 745
2022
Q2 		$226K Sell
19,595
-1,892
-9% -$22.3K 0.01% 700
2022
Q1 		$270K Buy
21,487
+5,112
+31% +$58.6K 0.01% 775
2021
Q4 		$191K Buy
+16,375
New +$201K 0.01% 836

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Prospera Financial Services's IRWD Position: Q4 2023 in Review

Prospera Financial Services sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2023, closing a stake of 26,067 shares — an estimated $251K sold.

Prospera Financial Services first reported a position in IRWD in Q4 2021 and held it in 8 quarters. The position peaked at $284K in Q4 2022. 251 funds tracked by Wall St. Rank hold IRWD as of Q4 2023.

  • Prospera Financial Services reported no remaining Ironwood Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Prospera Financial Services sold 26,067 Ironwood Pharmaceuticals shares in Q4 2023, an estimated $251K.
  • Prospera Financial Services first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Prospera Financial Services's Ironwood Pharmaceuticals position peaked at $284K in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2023.

Based on Prospera Financial Services's 13F filing for Q4 2023, filed 14 Feb 2024.